Febuxostat (TMX-67), a Novel, Non-Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers
Becker, M. A., Kisicki, J., Khosravan, R., Wu, J., Mulford, D., Hunt, B., MacDonald, P., Joseph-Ridge, N.
Published in Nucleosides, nucleotides & nucleic acids (31.12.2004)
Published in Nucleosides, nucleotides & nucleic acids (31.12.2004)
Get full text
Journal Article
Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
Lee, K.-W., Park, S. R., Oh, D.-Y., Park, Y.-I., Khosravan, R., Lin, X., Lee, S.-Y., Roh, E.-J., Valota, O., Lechuga, M. J., Bang, Y.-J.
Published in Investigational new drugs (01.12.2013)
Published in Investigational new drugs (01.12.2013)
Get full text
Journal Article
A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer
Gómez-Martín, C., Salazar, R., Montagut, C., Gil-Martín, M., Núñez, J. A., Puig, M., Lin, X., Khosravan, R., Tursi, J. M., Lechuga, M. J., Bellmunt, J.
Published in Investigational new drugs (01.04.2013)
Published in Investigational new drugs (01.04.2013)
Get full text
Journal Article
7165 POSTER Sunitinib (SU) Pharmacokinetic (PK)-Pharmacodynamic (PD) Modeling With Respect to Safety and Efficacy Endpoints in Asian Patients With Gastrointestinal Stromal Tumour (GIST) or Renal Cell Carcinoma (RCC) in Pursuit of a Therapeutic Window
Khosravan, R, Mugundu, G, Agata, N, Ueda, E, Nishida, T, Akaza, H
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors
Leong, S., Eckhardt, S. G., Chan, E., Messersmith, W. A., Spratlin, J., Camidge, D. R., Diab, S., Khosravan, R., Lin, X., Chow Maneval, E., Lockhart, A. C.
Published in Cancer chemotherapy and pharmacology (01.07.2012)
Published in Cancer chemotherapy and pharmacology (01.07.2012)
Get full text
Journal Article
Sunitinib (SU) pharmacokinetic (PK)–pharmacodynamic (PD) modeling with respect to safety and efficacy endpoints in Asian patients (pts) with gastrointestinal stromal tumor (GIST) or renal cell carcinoma (RCC) in pursuit of a therapeutic window
Khosravan, R., Mugundu, G., Agata, N., Ueda, E., Nishida, T., Akaza, H.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Sunitinib pharmacokinetic (PK) and safety data in subjects with renal impairment and on hemodialysis
Khosravan, R., Toh, M., LaFargue, J., Ni, G., Bello, C.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment
Mayer, Michael D, Khosravan, Reza, Vernillet, Laurent, Wu, Jing-Tao, Joseph-Ridge, Nancy, Mulford, Darcy J
Published in American journal of therapeutics (01.01.2005)
Published in American journal of therapeutics (01.01.2005)
Get more information
Journal Article
The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase
Khosravan, Reza, Grabowski, Brian A, Mayer, Michael D, Wu, Jing-Tao, Joseph-Ridge, Nancy, Vernillet, Laurent
Published in Journal of clinical pharmacology (01.01.2006)
Published in Journal of clinical pharmacology (01.01.2006)
Get more information
Journal Article
Febuxostat (TMX-67), a Novel, Non-Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers
Becker, M. A., Kisicki, J., Khosravan, R., Wu, J., Mulford, D., Hunt, B., MacDonald, P., Joseph-Ridge, N.
Published in ChemInform (01.03.2005)
Published in ChemInform (01.03.2005)
Get full text
Journal Article